๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of stage D prostatic carcinoma with megestrol acetate

โœ Scribed by Margaret Block; Philip Bonomi; Kenning Anderson; Janet Wolter; John Showel; Dennis Pessis; Robert Slayton

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
232 KB
Volume
17
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of anorexia and weight loss wi
Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis
โœ Samya Z. Nasr; Martin E. Hurwitz; Randall W. Brown; Mahmoud Elghoroury; David Ro ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 2 views

Four patients with severe cystic fibrosis lung disease, anorexia and weight loss, received Megestrol Acetate (MA), as an appetite stimulant. The initial dose was 400-800 mg daily and was continued for 6-15 months. Appetite was improved, with significant weight gain in all patients and an increase in

The dynamics of prostate specific antige
The dynamics of prostate specific antigen in hormone refractory prostate carcinoma : An analysis of Cancer and Leukemia Group B Study 9181 of megestrol acetate
โœ Robin T. Vollmer; Nancy A. Dawson; Nicholas J. Vogelzang ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 2 views

## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu